A pioneering technological advancement is currently under investigation at the Kennedy Krieger Institute, providing optimism for individuals who have sustained spinal cord injuries. This innovative device, known as “ExaStim,” holds the potential to facilitate movement and independence for those impacted by debilitating spinal cord trauma.
An individual benefiting from this extraordinary technology is Nathan Miller, who suffered a severe neck injury several years ago. Prior to his participation in the study, he experienced limited sensations and movements. However, with the assistance of ExaStim, Miller has undergone a remarkable improvement in his motor functions.
The non-surgical study, appropriately named “ASPIRE,” utilizes state-of-the-art stimulator to assist in the restoration of arm and hand functions in patients with spinal cord injuries. Dr. Rebecca Martin, a clinician at the Kennedy Krieger Institute, elucidates that the Transcutaneous Spinal Stimulation utilized in the study serves to increase the excitability of the central nervous system, thereby enabling patients to form new connections in the spinal cord.
Through this innovative approach, participants such as Nathan Miller have regained essential abilities including gripping, picking up objects, and improved stability. Dr. Martin further underscores the functional impact of the technology, noting that it empowers individuals to execute everyday tasks such as feeding themselves and grooming.
The study, which encompasses 14 distinct sites across the country, is being conducted solely at the Kennedy Krieger Institute in Maryland. With 10 participants enrolled in the program, the technology is demonstrating promising results. During the treatment sessions, an electrode is placed on the patient’s neck for an hour, complemented by specific exercises to augment the effects of the stimulation.
Dr. Martin underscores the adaptability of the treatment, with the capability to modify the level of stimulation based on the patient’s evolving requirements. The study is slated to conclude later this year, following which the device will undergo a phase of at-home testing to evaluate its effectiveness in sustaining the improvements achieved during therapy.
Remarkably, Nathan Miller, who has been on a hiatus from the device since November, continues to experience the benefits of the treatment, exhibiting sustained movement and function. His experience serves as evidence to the potential long-term impact of this pioneering technology.
Looking towards the future, the ultimate objective is to expand the utilization of this revolutionary device to enable patients to reacquire the ability to walk. The potential implications of this technology are extensive, offering hope to individuals affected by spinal cord injuries and the prospects of a significantly enhanced quality of life.
In conclusion, the ongoing investigation of ExaStim at the Kennedy Krieger Institute represents a substantial progression in the realm of spinal cord injury treatment. With its potential to reinstate mobility and function, this groundbreaking technology offers promise for individuals such as Nathan Miller and numerous others living with spinal cord injuries.
+ There are no comments
Add yours